Showing 3111-3120 of 3223 results for "".
- Envision Research Institute Announces Search for Post Doctoral Fellows to Study Low Visionhttps://modernod.com/news/envision-research-institute-announces-search-for-post-doctoral-fellows-to-study-low-vision/2479664/The Gigi & Carl Allen Envision Research Institute (ERI) is now calling for letters of intent to apply for its next round of postdoctoral research fellowships. Launched in 2015 with a goal to restore function to those who are blind and visually impaired, the ERI provides access to funds, facil
- New Melanoma Treatments Do Not Supplant Surgery as First-Line Therapyhttps://modernod.com/news/new-melanoma-treatments-do-not-supplant-surgery-as-first-line-therapy/2479670/Although several new melanoma treatments have shown promise, none replaces surgery as the primary therapy yet, according to updated guidelines from the American Academy of Dermatology (AAD), as reported in Reuters Health. “Su
- Small-Particle Air Pollution May Raise Glaucoma Risk in Somehttps://modernod.com/news/small-particle-air-pollution-may-raise-glaucoma-risk-in-some/2479675/In people who already have a genetic vulnerability, small-particle air pollution known as black carbon may raise the risk of developing glaucoma, a new study suggests, according to a Reuters report. Researchers found that in older
- Prospective Study for NaturalVue Multifocal Demonstrates Decreased Refractive Error Change in Fast-Progressing Myopic Childrenhttps://modernod.com/news/prospective-study-for-naturalvue-multifocal-demonstrates-decreased-refractive-error-change-in-fast-progressing-myopic-children/2479681/Thomas Aller, OD, presented updated findings from a prospective clinical trial of NaturalVue (etafilcon A) 1 Day Multifocal Contact Lenses at a briefing for media and industry leaders at the American Academy of Optometry (AAO) Conference in San Antonio on November 9. The NaturalVue portfolio of p
- Study Demonstrates Galimedix Therapeutics’ MRZ-99030 Eye Drops Neutralize the Reproduction of Misfolded Amyloid-Betahttps://modernod.com/news/new-in-vitro-study-demonstrates-galimedix-therapeutics-investigational-compound-mrz-99030-eye-drops-neutralizes-the-reproduction-of-misfolded-amyloid-beta/2479684/Galimedix Therapeutics announced the results of a new study at the Society for Neuroscience conference demonstrating that a single application of the investigational compound MRZ-99030, also known as GAL-101, causes sustained prevention of misfolded amyloid beta molecules from aggregating into to
- EHR Medication Lists Inaccurate, Incomplete, Blood Tests Showhttps://modernod.com/news/ehr-medication-lists-inaccurate-incomplete-blood-tests-show/2479689/Researchers who checked patients’ blood samples for medication concentration found that more than half were taking prescription and/or over-the-counter drugs not listed in their electronic health record (EHR), indicating potential threats to patient safety, according to a Medscape
- Unum Finds Significant Number of Millennials Value Vision Insurancehttps://modernod.com/news/unum-finds-significant-number-of-millennials-value-vision-insurance/2479704/Employee benefits provider Unum finds the elimination of vision benefits could motivate more than a third (34 percent) of U.S. workers ages 25 to 34 to look for a new job. These results and other key findings were part of an online poll among 1,227 working U.S. adults conducted by Unum in July.</
- FDA Warns Against Using Raindrop Near Vision Inlayhttps://modernod.com/news/fda-warns-against-using-raindrop-near-vision-inlay/2479749/The FDA today issued an alert about an increased risk for corneal haze in patients with the Raindrop Near Vision Inlay (Optics Medical). The FDA issued the alert after 75% of patients in a postapproval study of the device developed corneal haze, according to a
- IDx and Topcon Sign Exclusive AI Platform Agreement For the U.S. Markethttps://modernod.com/news/idx-and-topcon-sign-exclusive-ai-platform-agreement-for-the-u-s-market/2479766/AI diagnostics company IDx and Topcon have signed an exclusivity agreement that will allow the companies to scale delivery of AI-based diagnostic solutions in the United States. Terms of the deal were not disclosed. The agreement grants exclusive rights to IDx in the US as the only
- US Proposes Rule Requiring Drugmakers to Disclose List Prices of Drugs in DTC Advertisinghttps://modernod.com/news/us-proposes-rule-requiring-drugmakers-to-disclose-list-prices-of-drugs-in-dtc-advertising/2479780/US Health and Human Services Secretary Alex Azar announced a proposed rule change that would require pharmaceutical companies to provide the list prices of certain drugs in direct-to-consumer (DTC) advertising. Specifically, the proposal will require drugmakers to disclose in DTC television adver